Replies to post #253827 on NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

Wow. Thanks for sharing these stories. A continued frustration in not being able to improve the OS with SOC has a way of changing the attitudes of oncologists towards DCVax-l. Probably that is what happened in the case of Mitchell Berger of UCSF.